Article Figures & Data
Tables
Score Description 0 No symptoms at all 1 No significant disability despite symptoms: able to carry out all usual duties and activities 2 Slight disability: unable to carry out all previous activities, but able to look after own affairs without assistance 3 Moderate disability: requiring some help, but able to walk without assistance 4 Moderately severe disability: unable to walk without assistance and unable to attend own bodily needs without assistance 5 Severe disability: bedridden, incontinent, and requiring constant nursing care and attention 6 Death Originally published in van Swieten J, Koudstaal P, Visser M, et al. “Interobserver agreement for the assessment of handicap in stroke patients.” Stroke 1988;19:604-07.
Total (n = 136) Good Outcome (n = 29) Poor Outcome (n = 107) P Valuea Age (mean) (SD) 80.6 (10.1) 79.5 (13.2) 81.0 (9.2) .585 Female (No.) (%) 90 (66.2) 20 (69.0) 70 (65.4) .827 Diabetes (No.) (%) 34 (25.0) 5 (17.2) 29 (27.1) .340 Hypertension (No.) (%) 102 (75.0) 21 (72.4) 81 (75.7) .809 Arrhythmia (No.) (%) 84 (61.8) 19 (65.5) 65 (60.7) .674 Coronary heart disease (No.) (%) 41 (30.1) 8 (27.6) 33 (30.8) .822 Hypercholesterolemia (No.) (%) 41 (30.1) 8 (27.6) 33 (30.8) .822 Premorbid mRS (No.) (%) .719 3 111 (81.6) 23 (79.3) 88 (82.2) 4 25 (18.4) 6 (20.7) 19 (17.8) Baseline NIHSS (median) (IQR) 18 (15–22) 15 (12–19) 19 (15–23) .009 ASPECTS (median) (IQR) 9 (8–10) 10 (9–10) 9 (8–10) .051 Intravenous thrombolysis (No.) (%) 61 (44.9) 13 (44.8) 48 (44.9) 1.000 Onset-to-groin (median) (IQR) 240 (180–344) 232 (182–280) 247 (180–357) .250 Groin-to-TICI (median) (IQR) 75 (41–108) 63 (32–97) 77 (46–117) .142 Occlusion site (No.) (%) ICA 31 (22.8) 2 (6.9) 29 (27.1) .024 M1 78 (57.4) 15 (51.7) 63 (58.9) .530 M2 30 (22.1) 12 (41.4) 18 (16.8) .010 TICI 2b–3 103 (75.7) 27 (93.1) 76 (71.0) .014 Note:—IQR indicates interquartile range.
↵a Comparison between patients with good and poor outcomes.
Odds Ratio (95% CI) Adjusted P Value Baseline NIHSS 0.92 (0.85–0.99) .040 ASPECTS 1.45 (1.02–2.16) .049 ICA occlusion 0.31 (0.04–1.30) .152 M2 occlusion 2.35 (0.86–6.52) .097 TICI 2b–3 7.11 (1.73–49.90) .017 Premorbid mRS 3 (n = 111) Premorbid mRS 4 (n = 25) P Value TICI 2b–3 (No.) (%) 85 (76.6) 18 (72.0) .614 90-Day mRS (median) (IQR) 5 (3.5–6) 6 (4–6) <.001 Good outcome (No.) (%) 23 (20.7) 6 (24.0) .788 Hospital mortality (No.) (%) 17 (15.3) 6 (24.0) .231 Mortality at 90 days (No.) (%) 52 (46.8) 16 (64.0) .183